TRIM44 and Miyoshi myopathy: Based on our analysis of single-cell data (Figure 3 and Figure S3), which suggests TRIM44 roles in Bortezomib resistance, we hypothesized that TRIM44 could be crucial in modulating the drug responses of MM.